The study on the mixing ratio and the contrast effect of the test injection using a mixed solution of iodine contrast medium and saline

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1091220221

Enrollment

Registered

2015-08-19

Start date

2015-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Intervention type:DRUG Name of intervention:Non-ionic iodinated contrast agent Dose form / Japanese Medical Device Nomenclature:INJECTION Route of administration / Site of application:INTRAVENOUS BOLU

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Lung cancer before surgery patients was asked to 3DCTA of pulmonary artery and vein, it is possible the administration of contrast agent, That consent is obtained from the patient in writing about the study entry

Exclusion criteria

Exclusion criteria: Difficult cases respiratory arrest according to indication Such as a history of allergy to iodinated contrast material, administration of the same agents are inappropriate cases

Design outcomes

Primary

Measure	Time frame
correlation of test injection and actual injection of a contrast effect	—

Secondary

Measure	Time frame
test injection(maximum CT value contrast medium arrival time, maximum CT value),actual injection(maximum CT value contrast medium arrival time, maximum CT value)	—

Countries

Japan

Contacts

Public Contactnakane jun

Saitama Medical Center, Saitama Medical University

jun_n@saitama-med.ac.jp+81-49-228-3516

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026